Will prefer Covishield over Covaxin: Delhi docsJanuary 16, 2021 15:04
A Covishield vaccine dose
The Resident Doctors' Association of the Ram Manohar Lohia Hospital in New Delhi on Saturday requested the medical superintendent to vaccinate them with Oxford COVID-19 vaccine Covishield.
In a letter to the medical superintendent, the association said the resident doctors were "a bit apprehensive" about Covaxin and might not participate in the immunisation drive in large numbers thus defeating the purpose of the exercise which began in the country on Saturday.
"We have come to know that the COVID-19 vaccination drive is being conducted by the hospital today. Covaxin manufactured by Bharat Biotech is being preferred in our hospital over Covishield manufactured by Serum Institute.
"The residents are a bit apprehensive about the lack of complete trial in case of Covaxin and might not participate in huge numbers thus defeating the purpose of vaccination. We request you to vaccinate us with Covishield which has completed all stages of trial before its roll-out," the letter stated.
In the national capital, the vaccination exercise will be carried out at 81 sites across all its 11 districts.
At the RML hospital, a security guard was the first one to receive the shot.